InvestorsHub Logo

loanranger

03/09/24 10:57 PM

#401964 RE: williamssc #401961

I had seen that before and wondered if you had. So a laser surgery fiber is as critical to a laser surgery unit as a coffee filter is to a coffee machine. And the BeaMed fibers are identical to those already in existence.

Do I have that right?
If so, what kind of market size do you expect for this "new" product?

MackG

03/10/24 10:17 AM

#401968 RE: williamssc #401961

The number of surgical applications where the BeaMed StingRay laser can be utilized with superior advantages, including conforming the laser to the shape of the target without consequential damage to surrounding tissue will be a welcome and much needed improvement in many surgical applications. A large distribution network for the laser is already in place. IPIX owns approximately 42% of BeaMed Technologies, LTD. As a substantial investor, I could not be more excited at this pivitol point in time. You can learn more about it here: https://www.beam-med.com/

"The BeaMed Laser Surgery Fibers have a wavelength range of 450 nm to 2100 nm, can be
used in contact and non-contact mode and are indicated for use in general surgery, urology,
gastroenterology, gynecology, dermatology, vascular surgery, neurosurgery, plastic surgery,
ENT and endovenous occlusion of the greater saphenous vein in the patient with superficial
vein reflux and laser assisted lipolysis with a cleared compatible laser marketed for the
mentioned intended uses and using an SMA 905 connector."